Thus, the consistent changes in thyroid hormone pathway may possibly represent the cell from which the tumor originated, while different gene expression patterns of splicing factors may reflect later events in tumor growth, including mutations as well as epigenetic and chromosomal alterations. This evidence concerns the gene TG and neoplasm.